Charmaine Lykins

Insider Reports History

Location
Boston, MA
Signature
/s/ Charmaine Lykins
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charmaine Lykins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karuna Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 75,000 $6,922,500 $92.30 29 Nov 2021 Direct

Insider Reports Filed by Charmaine Lykins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924321046318-lykins-charmaine-2021-11-29 Karuna Therapeutics, Inc. 29 Nov 2021 1 $0 4 Chief Commercial Officer 30 Nov 2021, 16:12
/report/000089924321046317-lykins-charmaine-2021-11-29 Karuna Therapeutics, Inc. 29 Nov 2021 0 $0 3 Chief Commercial Officer 30 Nov 2021, 16:11